Masimo shares should be bought on weakness, says Roth Capital After Masimo reported higher than expected adjusted Q4 EPS and provided 2013 guidance.that Roth views as mixed, the firm thinks the company's guidance could be conservative. It maintains a Buy rating on the shares.
News For MASI From The Last 14 Days
Check below for free stories on MASI the last two weeks.
Masimo reports postive results from new study on acousting monitoring technology Masimo announced that a new study to be published in the June edition of the journal Anesthesia & Analgesia concludes that Acoustic Respiration Rate shows "significantly greater accuracy and precision for respiratory rate as compared to capnometry." Study results suggest that "the capnometer is about 3% less precise" than RRa.